Clinical Trials at USC

1503 Results for

Study Title	Principal Investigator
A Phase III Double Blind Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects With Chronic HCV GT1, GT4 and GT6 Infection With Inherited Blood Disorders With and Without HIV Co-Infection Active, not recruiting \| \| Site Unknown View full trial information >>	Medical Director
A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma Active, not recruiting \| Lymphoma \| Multisite View full trial information >>	Medical Monitor
Evaluating the Efficacy of a New Medication for Hidradenitis Suppurativa The purpose of the study is to evaluate if a new investigational medication, Bimekizumab, works for patients with hidradenitis suppurativa (HS). Earlier studies of Bimekizumab have shown that the medication is effective in patients with HS. This study compares the effects of Bimekizumab to an FDA-approved medicine, Adalimumab, and a placebo (no active medicine). To evaluate how well Bimekiumab works, we will perform a range of assessments to see how the severity of HS can decrease and quality of life could be improved. Not yet recruiting \| dermatology \| Not Multisite View full trial information >>	April W. Armstrong, MD MPH View Research Profile
<< < 22 23 24 25 26 ... 28 >>